Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at ...
The U.S. government shutdown has dragged into its 33rd day, and while a resolution may soon be approaching, economists warn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results